Improvement for subacromial steroid for rotator cuff tendonitis.
| Reference | Control n/total | Treatment n/total | Weight % | Relative risk (fixed) (95% CI) |
| 16 | 14/20 | 0/20 | 2.67 | 29.00 (1.85 to 455.25) |
| 17 | 16/19 | 8/21 | 40.63 | 2.21 (1.24 to 3.94) |
| 19 | 7/25 | 2/25 | 10.69 | 3.50 (0.80 to 15.23) |
| 20a | 11/16 | 0/5 | 3.95 | 8.12 (0.56 to 117.70) |
| 20b | 8/16 | 0/5 | 3.95 | 6.00 (0.40 to 88.93) |
| 21 | 9/28 | 7/27 | 38.10 | 1.24 (0.54 to 2.86) |
| Total | 65/124 | 17/103 | 100.00 | 3.08 (1.94 to 4.87) |
Test for hetrogeneity χ2 = 9.14, degrees of freedom = 5 (P = 0.10). Test for overall effect Z = 4.79 (P<0.00001). aArm with dexamethasone. bArm with triamcinolone.